Status:

COMPLETED

A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes

Lead Sponsor:

Eli Lilly and Company

Collaborating Sponsors:

Joslin Diabetes Center

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

18-70 years

Brief Summary

The main purpose of this study is to determine whether combining meal, glucose, and insulin data in a web-based system will improve management of type 1 diabetes (T1D). No study drug will be given. Th...

Eligibility Criteria

Inclusion

  • T1D by clinical diagnosis for \> 3 years
  • Insulin pump use \> 3 months: must use one of the following pump types: Animas Ping and Vibe, Insulet Omnipod, Medtronic 523/723 and 530G, Tandem t:slim and t:flex
  • Continuous Glucose Monitor (CGM) \> 3 months and current use of Dexcom G5 at least 6 out of 7 days per week
  • HbA1c 7.0-9.5%
  • Must have iPhone (meal-tagging app has been built on iOS)
  • Personal computer for uploading of pump and CGM devices
  • Willingness to follow study protocol including tagging food data
  • Comfort speaking, reading, and writing English

Exclusion

  • Individuals currently using a hybrid closed-loop system (e.g., Medtronic 670G)
  • Individuals planning to follow a specific diet plan for weight loss
  • Inability to consume "common meals"
  • Gastroparesis;
  • Eating disorder
  • Evidence of missed insulin meal-time insulin boluses on pump download
  • Use of medications that can affect blood glucose levels (such as SGLT inhibitors, steroid, beta agonists)
  • Use of medications that affect gastric emptying (such as GLP agonists, pramlinitide)
  • Alcohol abuse
  • Pre-conception, pregnancy, or lactation

Key Trial Info

Start Date :

February 6 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 7 2020

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT03758430

Start Date

February 6 2019

End Date

August 7 2020

Last Update

August 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Joslin Diabetes Center

Boston, Massachusetts, United States, 02215

A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes | DecenTrialz